Power and sample size calculations for stochastic cost-effectiveness analysis
- PMID: 9566469
- DOI: 10.1177/0272989X98018002S10
Power and sample size calculations for stochastic cost-effectiveness analysis
Abstract
As the data for economic analyses are increasingly collected prospectively alongside clinical trials, many commentators have highlighted that the sample sizes in such trials should be based on the requirements for the economic analysis as well as those for the clinical evaluation. However, issues associated with sample size calculations for economic analysis have yet to receive the rigorous attention given to sample size calculation for clinical evaluation. In particular, no sample size formula for cost-effectiveness analysis is available for analysts hoping either to calculate the required sample size at the design stage of a study or to calculate the power a given size of clinical trial will generate for cost-effectiveness analysis. Building on the recent literature for calculating confidence intervals for cost-effectiveness ratios, the authors explore possible techniques for deriving a sample size formula for cost-effectiveness analysis based on simple combination of the confidence limits on costs and effects.
Similar articles
-
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.Health Econ. 1999 May;8(3):203-11. doi: 10.1002/(sici)1099-1050(199905)8:3<203::aid-hec413>3.0.co;2-7. Health Econ. 1999. PMID: 10348415
-
Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.Pharmacoeconomics. 2002;20(15):1061-77. doi: 10.2165/00019053-200220150-00003. Pharmacoeconomics. 2002. PMID: 12456201
-
Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.Annu Rev Public Health. 2002;23:377-401. doi: 10.1146/annurev.publhealth.23.100901.140534. Epub 2001 Oct 25. Annu Rev Public Health. 2002. PMID: 11910068 Review.
-
A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.Comput Methods Programs Biomed. 2013 Jun;110(3):471-89. doi: 10.1016/j.cmpb.2013.01.008. Epub 2013 Feb 8. Comput Methods Programs Biomed. 2013. PMID: 23399102
-
Design and analysis issues for economic analysis alongside clinical trials.Med Care. 2009 Jul;47(7 Suppl 1):S14-20. doi: 10.1097/MLR.0b013e3181a31971. Med Care. 2009. PMID: 19536012 Review.
Cited by
-
Design of Economic Evaluations of Mindfulness-Based Interventions: Ten Methodological Questions of Which to Be Mindful.Mindfulness (N Y). 2015;6(3):490-500. doi: 10.1007/s12671-014-0282-6. Mindfulness (N Y). 2015. PMID: 26000063 Free PMC article.
-
Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials.BMC Health Serv Res. 2012 Sep 15;12:318. doi: 10.1186/1472-6963-12-318. BMC Health Serv Res. 2012. PMID: 22978572 Free PMC article. Clinical Trial.
-
A new approach for sample size calculation in cost-effectiveness studies based on value of information.BMC Med Res Methodol. 2018 Oct 22;18(1):113. doi: 10.1186/s12874-018-0571-1. BMC Med Res Methodol. 2018. PMID: 30348087 Free PMC article.
-
Protocol for north of England and Scotland study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC). A pragmatic randomised controlled trial comparing surgical intervention with conventional medical treatment in children with recurrent sore throats.BMC Ear Nose Throat Disord. 2006 Aug 9;6:13. doi: 10.1186/1472-6815-6-13. BMC Ear Nose Throat Disord. 2006. PMID: 16899123 Free PMC article.
-
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.BMC Med Res Methodol. 2023 Aug 3;23(1):179. doi: 10.1186/s12874-023-01956-y. BMC Med Res Methodol. 2023. PMID: 37537545 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials